Sirnaomics

Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company headquartered in Gaithersburg, Maryland, founded in 2007 and listed on the Hong Kong Stock Exchange (2257.HK). The company focuses on the discovery and development of innovative RNA-targeted drugs and was the first to achieve positive Phase IIb clinical outcomes in oncology RNA therapeutics.